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The cardiac homeobox gene Nkx2.5 plays a key and dosage-sensitive role in the differentiation of
outﬂow tract and right ventricle from progenitors of the second heart ﬁeld (SHF) and Nkx2.5mutation is
strongly associated with human outﬂow tract congenital heart disease (OFT CHD). Therefore deﬁning
the regulatory mechanisms controlling Nkx2.5 expression in SHF populations serves an important
function in understanding the etiology of complex CHD. Through a comparative analysis of regulatory
elements controlling SHF expression of Nkx2.5 in the chicken and mouse, we have found evidence that
Nkx2.5 autoregulation is important for maintaining Nkx2.5 expression during SHF differentiation in
both species. However the mechanism of Nkx2.5 maintenance differs between placental mammals and
non-mammalian vertebrates: in chick Nkx2.5 binds directly to a genomic enhancer element that is
required to maintain Nkx2.5 expression in the SHF. In addition, it is likely that this is true in other non-
mammalian vertebrates given that they possess a similar genomic organization. By contrast, in
placental mammals, Nkx2.5 autoregulation in the SHF functions indirectly through Mef2c. These data
underscore a tight relationship in mammals between Nkx2.5 and Mef2c in SHF transcriptional
regulation, and highlight the potential for evolutionary cis-regulatory analysis to identify core,
conserved components of the gene networks controlling heart development.
Published by Elsevier Inc.Introduction
Second heart ﬁeld development and outﬂow tract congenital heart
disease
Outﬂow tract (OFT)-associated malformations of the aorta and
pulmonary artery comprise a signiﬁcant proportion of all
congenital heart disease (CHD) with an overall prevalence of
200–400,000 in the US population alone (Lloyd-Jones et al., 2010).
A principle source of myocardial, smooth muscle and endothelial
progenitors that contribute to the OFT is the second heart ﬁeld
(SHF) and misspeciﬁcation of the SHF plays a critical role in the
genesis of CHD in animal models. Because of this, factors regulat-
ing the development of the SHF are the topic of intense study in
the ﬁeld of cardiac embryology. The SHF is deﬁned as a phar-
yngeal mesoderm population whose differentiation and contribu-
tion to the developing heart is distinct from that of the cardiac
crescent or ﬁrst heart ﬁeld (FHF) that primarily contributes to theInc.
mental Biology Center,
C 508, 173 Ashley Avenue,left ventricle. The SHF, together with the more spatially restricted
secondary heart ﬁeld (Waldo et al., 2001), gives rise to OFT and
right ventricle (Cai et al., 2003; Kelly, 2012; Kelly et al., 2001;
Meilhac et al., 2004; Zaffran et al., 2004).
Nkx2.5 in OFT CHD
A gene high in the hierachy of SHF regulation and one
frequently associated with OFT CHD in humans is the cardiac
homeobox gene Nkx2.5. It is estimated that Nkx2.5 mutations
account for approximately 4% of human cardiovascular malfor-
mations (Benson, 2010). Point mutations that create hypomorphic
alleles of the Nkx2.5 gene have been implicated in familial,
sporadic, syndromic and non-syndromic CHD. In particular, both
Tetralogy of Fallot (TOF), a cardiac looping defect leading to
pulmonary artery stenosis with secondary right ventricular
hypertrophy, ventricular septal defect, and overriding aortic
valve; and secundum atrial septal defect without atrio-
ventricular conduction delay are associated with Nkx2.5 muta-
tions (Goldmuntz et al., 2001; McElhinney et al., 2003). Loss of
function experiments in mice reveal that Nkx2.5 regulation is
critical for normal SHF development: OFT malformations of
increasing severity are observed with progressively lower levels
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alleles (Lints et al., 1993; Prall et al., 2007; Tanaka et al., 1999)
likely due to altered regulation of direct or indirect Nkx2.5 target
genes (Barth et al., 2010; Kasahara et al., 2000, 2001; Prall et al.,
2007). Given the strong relationship between Nkx2.5 expression
levels in the SHF and normal development, an important aspect of
OFT morphogenesis is the cis-regulation of Nkx2.5 in SHF pro-
genitors and differentiating myocytes of the aortic pole. Nkx2.5
likely functions within a complex network of transcription fac-
tors, growth factors, matrix molecules and other determinants of
cell phenotype collaboratively controlling heart formation. Unra-
veling the normal connections of Nkx2.5 to these other pathways
is therefore an important step towards better understanding
genetically complex CHD, and has the potential to help deﬁne
new disease causing genes (Benson, 2010; Granados-Riveron
et al., 2011).Materials and methods
Vectors and plasmids
Chicken Nkx2.5 reporters: cloning of wild-type chicken Nkx2.5
reporter constructs, including: Nkx2.5-lux-CAR3, Nkx2.5-lacZ-
CAR3, and Nkx2.5-lux-BMPRE have been previously described
(Lee et al., 2004). BMPRE linker scanning mutant m5 was created
by PCR mutagenesis substituting bps 35–45 of a 200 bp BMPRE
cassette with a modiﬁed NotI restriction site using the oligonu-
cleotide and its complement: 30-CAG TCA AAA CAT CGC GGC CGC
GTC TGA GAT TGT CC-50 (IDTDNA, Coralville, IA) and the Quik-
Change site-speciﬁc mutagenesis kit (Stratagene, LaJolla, CA).
Similarly, the Nkx2.5 binding consensus mutation (nm) was
created in 200 bp BMPRE and 2 kb CAR3 enhancer cassettes using
the oligonucleotide 50–CAG TCA AAA CAT CCT CCG AGT CTG AGA
TTG TCC-30 and its complement. Mutagenized BMPRE and CAR3
cassettes were ligated 30 of the Nkx2.5 promoter–reporter con-
structs expressing lacZ, or luciferase coding region derived from
the pGL3 basic plasmid (Promega, Madison, WI) or NLS cre
recombinase (a kind gift of F. Alt) fused in-frame with the ﬁrst
10 amino acids of the chicken Nkx2.5 coding region. The CNkx2.5-
SHF-lacZnm reporter additionally contained a 50 HS4 insulator
sequence from the chicken ß-globin locus (Chung et al., 1993) (a
kind gift of G. Felsenfeld).
Mouse Nkx2.5 reporter genes; Mouse Nkx2.5 lacZ and lux
reporter genes were created by PCR amplifying the 494 bp
conserved 50 mouse Nkx2.5 enhancer (representing nt (9109)
to (9603) relative to transcriptional initiation site of Nkx2.5,
accession number NM_008700.2) from C57BL6 genomic DNA
using the oligonucleotides 50-GGC CTC GAG CCT CGC TCC AGT
CAA ACT TC-30 and 50-GGC CTC GAG TTG GCT GTT CCT TGT GTT-30
and cloning the obtained fragment into a 50 XhoI site of the
chicken Nkx2.5 endogenous minimal promoter–reporter (above
and Lee et al., 2004). Mutation of the consensus Mef2 site at nt
(9218) to (9226) was accomplished using PCR-mediated site-
speciﬁc mutagenesis as above using the oligonucleotide 50-AAT
CGA TAG GGC CCT TTC GAA TAG CTC CGA GTT TCC TGT CGG-30
and its complement. Similarly, conversion of the Mef2 CArG site
to an Nkx2.5-binding NKE element was accomplished using the
oligonucleotide: 50-GGG AAG ATA AAG TAA TCG ATA GGA GAC
ACA CTC AGA GGC CGA GTT TCC TGT CGG GCC AGG -30 and its
complement.
Mouse lines and generation of knockout embryos
Nkx2.5 wild-type, heterozygous and null embryos were gen-
erated through timed mating, maternal sacriﬁce and embryocollection from Nkx2.5-lacZ knock-in heterozygous mice (a kind
gift of W. Pu) and genotyped according to previously described
methods (Tanaka et al., 1999). Mef2c knockout mice were gener-
ated from mice bearing a conditional null allele of Mef2c (Arnold
et al., 2007) (a kind gift of E. Olson) by germline deletion through
mating to EIIa-Cre driver mice (Jackson Labs, Bar Harbor, ME).
Mef2c wild-type, heterozygous and null embryos were generated
as above and genotyped as previously described (Arnold et al.,
2007).
Transient and stable transgenic mouse assays
Mouse and chicken Nkx2.5-SHF wild-type and mutant reporter
constructs were puriﬁed from their pBluescript backbones by
restriction digestion, gel electrophoresis and extraction using
QIAEX bead afﬁnity puriﬁcation (Qiagen, Valencia, CA). Linear
DNA was introduced by pronuclear injection into one-cell staged
FVB mouse embryos according to standard methods. F0 embryos
were collected at 7.5–10.5 days post-injection following maternal
sacriﬁce, ﬁxed and stained for ß-galactosidase activity according
to previously described methods (Zimmerman et al., 1994).
Transgenic status of individual embryos was determined by PCR
from DNA derived from yolk sacs and embryo fragments using
oligonucleotides for lacZ: 50-CGG CCA GGA CAG TCG TTT GCC GTC
TG-30 and 50-CCT GAC CAT GCA GAG GAT GAT GCT CG-30; and, for
the constitutive gene Prx1: 50-CCT GAG TTA CCT GCA CTC TG030
and 50-AGG ACT GAG GAG GAT TCT TG-30. Stable lines were
obtained by mating fully-grown F0 to wild-type FVB mice, and
screening progeny by PCR of genomic DNA derived from tail
preparations as above, and for Cre sequences using oligonucleo-
tides 50-CCT GGA AAA TGC TTC TGT CCT-30 and 50-CAG GGT GTT
ATA AGC AAT CCC-30. Lineage tracing of CNkx2.5-SHFnm-cre
bearing lines was accomplished using timed matings of Cre lines
to the conditionally activated LacZ cre reporter mouse line R26R
Rosa-LacZ (Jackson Labs, Bar Harbor, MN), followed by embryo
harvest, genotyping and LacZ staining as above. For section
analysis, whole-mount stained embryos were dehydrated
through a graded alcohol series, equilibrated in HistoClear
(National Diagnostics, Atlanta, GA) and paraplast-embedded prior
to sectioning, de-parafﬁnization in xylene, counterstain with
eosin and mounting in Permount (Sigma–Aldrich, St. Louis MO).
In vivo cellular reporter assays
BMP and overexpression reporter gene assays were performed
in P19CL6 cells as previously described (Lee et al., 2004). All assay
results are presented as fold induction of duplicate unstimulated
versus BMP-stimulated activities; all transfections are represen-
tative of 3 independent experiments. pCS2Nkx2.5 and
pCS2Nkx2.5 (Ile183-Pro) were a kind gift from S. Izumo and H.
Kasahara. pCS2 MT-Smad1, pCS2 MT/Flag Smad4 and pCS2 Alk3n
were a kind gift from M. Whitman. pcDNA rat GATA-4 was
derived from pCG-GATA-4, a kind gift of M. Nemer. pcDNA mouse
GATA-6 was a kind gift of T. Collins. pcDNA SRF was a kind gift of
E. Olson. pCMV-SPORT6 Mef2c (based on cDNA accession number
BC026841) was purchased from Thermo Scientiﬁc (OpenBiosys-
tems, Huntsville, AL). Recombinant BMP4 and Noggin was pur-
chased from R&D Systems (Minneapolis, MN). Statistical
signiﬁcance of reporter gene activation was calculated using
Student’s t-test with signiﬁcance threshold of pr0.01.
Gel shift assays
Gel shift assays were performed as previously described (Lee
et al., 2004) using nuclear extracts prepared from HEK293 cells
programmed to express Nkx2.5, SRF or Mef2c using 0.5–1.0 ug
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gen, Carlsbad, CA) at 4 1C, dried and autoradiographed on Kodak
XAR X-ray ﬁlm for digitization. Gel shifts were also performedFig. 1. Nkx2.5 directly regulates the CNkx2.5-SHF enhancer. (A) A schematic of the 20
(green circles), GATA4/6 (red and orange squares) and YY1 (blue rectangle) binding elem
an Nkx2.5 binding consensus (yellow rectangle). The 10 bp M5 linker scanning mutatio
shown over the affected nucleotides in red, as is the smaller 3bp mutation (designated
mediated reporter gene activation of wild-type Nkx2.5-lux-BMPRE reporter or reporter b
results in an approximately 50% decrease in BMP induced Nkx2.5-lux-BMPRE driven l
activity. (C) Data are shown for gel shifts performed with control (lanes 1 and 2), or Nk
Smad4-MH1 domain proteins (lanes 7 and 8). Gel shifts were performed using doubl
(lanes 1, 3, 5, and 7) or the Nkx2.5 consensus bearing the nm mutation (lanes 2, 4, 6, 8).
selective enrichment (approx. 15 ) of amplicons from the BMPRE surrounding the N
appreciable enrichment is observed of control GFP coding regions of the reporter (con
CNkx2.5-SHF-lux luciferase activity in response to BMP (second column set from left),
6 increases BMP activation of Nkx2.5-SHF-lux approximately 20-fold. The BMP response
to Nkx2.5 and SRF, GATA4/6, SRF, Myocardin and p300 co-expression and BMP stimul
binding site on the CNkx2.5-SHF enhancer as compared to wild-type enhancer (WT). (G)
reduced approximately 75% by use of a mutated non-DNA binding Nkx2.5 isoform (DNusing GST – Smad4 MH1 domain fusion proteins and control GST
proteins as previously described (Lee et al., 2004). Gel shifts were
performed using the following end-P32 labeled double stranded0 bp BMPRE of the chick Nkx2.5 gene depicting previously characterized Smad4
ents is shown over an expanded view of nt 35–50 (Lee et al., 2004) which contains
n of BMPRE (nt 37–47) overlapping Nkx2.5 and Smad4 binding consensus sites is
Nkx2.5 mutant or nm) speciﬁcally targeting the Nkx2.5 binding element. (B) BMP-
earing the M5 or 3bp nmmutations of the Nkx2.5 consensus site. TheM5 mutation
uciferase activity while the nm mutation results in a 4-fold decrease in luciferase
x2.5 cell extracts (lanes 3 and 4), or puriﬁed control GST (lanes 5 and 6) and GST-
e stranded oligonucleotides representing the wild-type BMPRE Nkx2.5 consensus
(D) ChIP assay of Nkx2.5 binding to CNkx2.5-SHF-GFP reporter detects speciﬁc and
kx2.5 binding consensus (Nkx site) using a-Nkx2.5 antibody vs. control IgG. No
trol). (E) While addition of Nkx2.5 alone does not lead to a signiﬁcant increase in
combinatorial addition of SRF, SRF cofactor Myocardin and cardiac GATAs 4 and
is further ampliﬁed 50–100 fold by addition of p300. (F) CNkx2.5-SHF-lux response
ation is reduced approximately 70% by site-speciﬁc mutation (nm) of the Nkx2.5
Multi-TF and BMP activation of the wild-type CNkx2.5-SHF-lux reporter is similarly
Nkx2.5) as compared to wild-type (WT Nkx2.5).
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ACA TCC TCT GAG TGT CTG AG-30; Nkx2.5 (NKE mut) 50-ACA TCC
TCT GCG AGT CTG AG-30; mNkx2.5 Mef2 binding site: 50-TAA TCG
ATA GGG CCC TTT TAA ATA GCT CCG AGT TTC CTG TCG G-30;
mNkx2.5 Mef2 binding site mutant: 50-AAT CGA TAG GGC
CCT TTC GAA TAG CTC CGA GTT TCC TGT CG-30; control Mef2c
binding site: 50-CGC TCT AAA AAT AAC CCT-30; control Mef2c
binding site (mutant): 50-CGC TCT AAG GCT ACC CT-30 (Yu et al.,
1992). Gel shift quantiﬁcation of Smad4 binding was calculated
from digitized autoradiogram images using ImageQuantTL (v7.0)
software (GE, Fairﬁeld, CT)
Chromatin immunoprecipitation Assays (ChIP)
Chromatin extracted from wild-type FVB E10.5 mouse hearts
were assayed by ChIP according to previously described methods
(Barth et al., 2010) using anti-Mef2c antibody (Sigma–Aldrich,
]HPA005533) or antiserum for Nkx2.5 (a kind gift of C. Carlson
and A. Ansari) and primers 50 CTC TGC TGT GTG GCC TTG TA-30
and 50-CGA CAG GAA ACT CGG AGC TA-30 (rev) (mNkx2.5 SHF
region); 50-CTC CTG CAA GGA GAT TGC TC-30 (for) and 50-CCT CAC
CAG CCC ATT TAG TG-30 (rev) (mNkx2.5 promoter region); and, 50-
CTA CAA GTG CAA GCG ACA GC-30 (for) and 50-GCG TTG TAG CCA
TAG GCA TT-30 (rev) (mNkx2.5 exon 2). Results are expressed as
fold enrichment based upon DC(t) calculations compared to
control antiserum or control Ig. For ChIP assay of chick Nkx2.5-
SHF reporters, P19CL6 cells were seeded in 60 mM dishes as
described above transfected after overnight incubation with
0.4 ug each CNkx2.5-SHF–GFP reporter and pCS2 Nkx2.5 expres-
sion vector. Cells were then formaldehyde ﬁxed and harvested
chromatin subject to overnight immunoprecipitation with either
control IgG or anti-Nkx2.5 antibody (H-114, sc-14033, Santa Cruz
Biotechnology, Santa Cruz, CA). Precipitated chromatin was
assayed by qPCR using primers 50-TAC AGT AGT CAC TAT TAA
ATG-30 (for) and 50-TGT GCG GTT GGT CCC TTC GGG-30 (rev)
(CNkx2.5 BMPRE region); and 50-CTG CTG CCC GAC AAC CAC-30
(for) and 50 GCT CGT CCA TGC CGA GAG TGA-30 (rev) (GFP
reporter region). Results are expressed as fold enrichment based
upon DC(t) calculations compared to control antiserum or control
Ig as above.Results
Nkx2.5 enhancer analysis identiﬁes an autoregulatory role for Nkx2.5
in the SHF
In previous studies of the chicken Nkx2.5 gene we identiﬁed a
BMP-responsive enhancer region that controls Nkx2.5 expression
in SHF cardiac progenitors and in the SHF (Lee et al., 2004). A lacZ
reporter transgene driven by this enhancer (CNkx2.5-SHF-lacZ) is
activated at mouse E8.5 in pharyngeal arch mesoderm and
ectoderm, and continues to express lacZ activity in pharyngeal
arch (PA) mesoderm, OFT and RV through E10.5. A linker scanning
mutagenesis of the central 200 bp BMP response element
(BMPRE) within the SHF enhancer identiﬁed several transcription
factor (TF) binding sites critical for enhancer activation in vitro
and for cardiac reporter gene expression in vivo. These included
consensus binding sites for the cardiac TFs Gata4 and Gata6, for
the BMP/TGFb signal transducing Smad4 protein, and for the
Smad complex-binding activator/repressor YY1 (Lee et al., 2004;
Lee and Lassar, unpublished).
As an extension of these studies we characterized an additional
BMPRE linker-scanning mutant that overlaps a potential consen-
sus binding site for Nkx2.5 (M5; Fig. 1A) and which reduces the
activation of a corresponding Nkx2.5 luciferase reporter, CNkx2.5-BMPRE-lux M5 (Fig. 1B). Gel shift and EMSA experiments conﬁrm
that this enhancer region binds Nkx2.5 in vitro (Fig. 1C, left panel),
and chromatin immunoprecipitation (ChIP) experiments in P19
cells transfected with a CNkx2.5-SHF reporter and an Nkx2.5
expression plasmid demonstrate interaction of Nkx2.5 with the
BMPRE region containing the Nkx2.5 binding site in vivo (Fig. 1D).
Both the 10 bp linker scanning M5 mutation and a more speciﬁc
2 bp mutation (nm) of the consensus NKE abrogate Nkx2.5 gel
shift binding, and the nm mutation also reduces reporter gene
activation (Fig. 1B and C). Perhaps due to its proximity to the Nkx
binding site, Smad4 interaction at an adjacent Smad binding site is
also somewhat affected (reduced by 23%) in gel shifts of double
stranded DNA oligos bearing either the M5 or the nm mutation
(Fig. 1C, right panel). While targeted mutation of the Smad4
binding site leads to complete loss of BMP response in cell assays
and reporter gene expression in vivo (Lee et al., 2004), both M5
and nm mutant reporters are still activated by BMP (Fig. 1B).
Nkx2.5 overexpression alone has no signiﬁcant effect on basal
or BMP-mediated activation of the CNkx2.5-SHF-lux reporter
(Fig. 1E, left columns). However, since Nkx2.5 can synergistically
activate cardiac-speciﬁc genes when co-expressed with other
early cardiac TFs (Chen et al., 1996; Lee et al., 1998) we
investigated whether the CNkx2.5-SHF-lux reporter could be
activated by a combination of Nkx2.5 and other TFs known to
bind to Nkx2.5 through protein-protein interaction. As shown in
Fig. 1E, co-expression of Nkx2.5 with serum response factor (SRF)
(Chen and Schwartz, 1996) and its co-activator Myocardin (Wang
et al., 2001) results in an approximate 10-fold activation of both
basal and BMP-stimulated levels. Activation of the CNkx2.5-SHF-
lux reporter by Nkx2.5, SRF and Myocardin is further increased
(from 2-fold to approximately 20-fold) by the expression of Gata4
and 6. This is not surprising since Gata4 is capable of protein–
protein interaction with both SRF and Nkx2.5 (Belaguli et al.,
2000; Lee et al., 1998; Sepulveda et al., 1998). However, consis-
tent with our previous ﬁndings, Gata4/6 expression alone is
insufﬁcient for activation of the CNkx2.5-SHF-lux reporter (Lee
et al., 2004) (Fig. 1E). The transcriptional co-activator p300, which
associates with GATA factors and Myocardin (Cao et al., 2005; Dai
and Markham, 2001), also increases basal and BMP-stimulated
activity a further 2.6–3 fold for a cumulative 50-fold increase of
basal activity and 100-fold increase in BMP-stimulated activity
(Lee et al., 2004).
Importantly, this high level activation of the by multiple
cardiac TFs is dependent upon binding of Nkx2.5 to its consensus
site: both basal and BMP-stimulated activation by the combina-
tion of Nkx2.5, SRF, Myocardin, Gata4/6 and p300 was strikingly
reduced in enhancer reporters incorporating the nm Nkx2.5
binding site mutation (CNkx2.5 nm-SHF-lux) (Fig. 1F). Similarly,
substitution of WT Nkx2.5 with a dominant negative Nkx2.5
protein that does not bind DNA (Kasahara et al., 2001) results in
greatly reduced activation of the wild-type CNkx2.5-lux-SHF
reporter (Fig. 1G). Cumulatively, these results deﬁne a require-
ment for Nkx2.5 autoregulation in the multi-TF activation of
theCNkx2.5-SHF enhancer in vitro.
Nkx2.5 autoregulation maintains expression in cardiomyocytes
during differentiation from SHF progenitors
In order to assess the role of this Nkx2.5 autoregulationon
expression in vivo, stable mouse lines were generated incorporating
a transgenic reporter (CNkx2.5-SHFnm-lacZ) that expresses b-gal
under control of the CNkx2.5-SHF enhancer containing the nm
mutation (Fig. 2). We have previously described the expression of
the CNkx2.5-SHF-lacZ enhancer (Lee et al., 2004). As with the
unmutated enhancer, bilaterally symmetric Xgal staining is ﬁrst
observed in SHF splanchnic mesoderm in the pharyngeal arch region
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into the heart tube established by the primary or ﬁrst heart ﬁeld.
Expression continues to be observed in pharyngeal endoderm andthe splanchnic mesoderm of the SHF through E10.5 (Fig. 2D–F).
However, and in contrast to the WT CNkx2.5-SHF-lacZ reporter,
which continues to express lacZ in differentiated heart (Lee et al.,
C.D. Clark et al. / Developmental Biology 374 (2013) 198–209 2032004), the mutant CNkx2.5-SHFnm-lacZ reporter fails to maintain
expression in the OFT, RV and interventricular septal region at E10.5,
although some residual lacZ expression is observed in SHF meso-
dermal cells and cells of the proximal OFT/aortic sac region.
Xgal staining is not observed in adult transgenic hearts (data not
shown).
To test whether lacZ expressing cells marked by the CNkx2.5-
SHFnm-lacZ reporter in E8.5 pharyngeal arch mesoderm include
SHF precursors, transgenic lineage marking analysis was per-
formed with mouse lines expressing Cre recombinase under
control of the CNkx2.5-SHFnm enhancer (CNkx2.5-SHFnm-cre). In
situ hybridization using a probe speciﬁc for Cre mRNA conﬁrmed
that the CNkx2.5-SHFnm-cre transgene drives Cre mRNA expres-
sion in a pattern identical to the lacZ expression seen with the
CNkx2.5-SHFnm-lac Zenhancer (Fig. 2G–I). To determine the fate
of cells marked with this transgene, CNkx2.5-SHFnm-cre mice
were crossed with the conditional ﬂoxed lacZ reporter mouse
line R26R Rosa-lacZ which permanently marks cells that have
expressed the Cre transgene at any point during differentiation
(Soriano, 1999). Mice derived from this cross showed Xgal
positivity in cells of the splanchnic mesoderm, foregut endoderm
and branchial arch ectoderm, as well as SHF-derived OFT and RV
in CNkx2.5-SHFnm-creþ /; R26RlacZþ / double-positive embryos
at E10.5 (Fig. 2J–L). Cells of the left ventricle (LV) and atria remain
unmarked conﬁrming that the CNkx2.5-SHFnm-cre expression was
restricted to SHF progenitors. This SHF-speciﬁc fate map is
qualitatively similar both to the expression pattern of CNkx2.5-
SHF-lacZ (Lee et al., 2004), and to a fate map obtained using a WT
CNkx2.5-SHF-cre driver line (Fig. 2M–O). These results are con-
sistent with a model whereby enhancer autoregulation by
Nkx2.5-recruited TF complexes is dispensable for early activation
in SHF progenitors, but is required for maintenance of expression
in differentiated myocytes derived from these progenitors after
they have entered the heart.
Some ectopic lacZ reporter activation is observed in OFT cushions
using the CNkx2.5-SHFnm-cre as compared to the lineage tracing
obtained with the wild-type enhancer and craniofacial ectodermal
lineages are marked in both lineage traces (Fig. 2J and L compared to
M and O) indicating transient expression in ectoderm and a
transient repressive role for Nkx2.5 autoregulation in neural crest
or OFT endocardial lineages that was not appreciated with our
previous WT CNkx2.5-SHF-lacZ studies. While Nkx2.5 expression has
not been reported in migratory or post-migratory neural crest cells,
it is transiently expressed in anterior ectoderm at the border of the
neural plate and non-neural ectoderm in chicken (Schultheiss et al.,
1995). As this region later gives rise to dorsal neural tube from
which CNCC are derived, the ectopic expression in OFT cushions
may in part represent a speciﬁc loss of appropriate Nkx2.5-mediated
repression in these CNCC precursors that is speciﬁc to the chick SHF
enhancer. These results are also consistent with previous lineage
tracings achieved with an mNkx2.5–30 UTR-IRES-Cre allele that, in
addition to marking craniofacial ectoderm populations, also marked
OFT cushion cells in mosaic fashion that were likely derived from an
endocardial or bi- or multi-potent Nkx2.5 (þ) lineage (Stanley et al.,Fig. 2. Nkx2.5 autoregulation is required for Nkx2.5-SHF enhancer expression in aor
expression patterns of stable lines transgenic for the CNkx2.5-SHFnm-lacZ reporter co
endoderm is similar to that seen with the wild-type Nkx2.5 SHF enhancer construct (L
progenitors, but absent in FHF-derived heart. D–F: While still expressed in PA regions, C
RV of E10.5 transgenic embryos except in a few cells of the SHF (F, black arrowheads).
expression in CNkx2.5-SHFnm-cre stable transgenic mouse line (nm cre). Cre is express
mesoderm (black arrowheads) at E8.5 (6 somite stage) (I) and retained primarily in phar
strain and CNkx2.5-SHFnm-cre driver at E10.5 conﬁrms that Cre expression from the
progenitors (black arrowheads) and OFT and right ventricular segments of the heart sim
arch; LV: left ventricle; RA: right atrium; RV: right ventricle; OFT: outﬂow tract; Ao: ao
PE: pharyngeal endoderm; AS: aortic sac; EC: endocardium. Dotted lines in A, B, and I2002) and that at E9.5 may represent the majority of OFT
cushion cells.
Conservation of Nkx2.5 SHF regulatory elements among vertebrates
We next examined whether Nkx2.5 autoregulation of its SHF
expression is an evolutionarily conserved mechanism. A com-
parative genomic analysis of Nkx2.5 genes of available vertebrate
species revealed that a 250 bp element highly similar to a central
region of the 2.0 kb CNkx2.5-SHF enhancer module is highly
conserved in the 30 ﬂanking genomic regions of the turkey
(Meleagris gallopavo) Budgarigar or parakeet (Melopsittacus unda-
latus), medium ground ﬁnch (Geospiza fortis), zebra ﬁnch (Taenio-
pigea guttata), frog (Xenopus tropicalis) and opossum (Monodelphis
domestica) Nkx2.5 genes (Fig. 3A). This region of conservation
contains the BMPRE and conserved GATA, YY1 and Smad4 con-
sensus binding sites that are essential for BMP response and SHF
expression of the chicken Nkx2.5 SHF enhancer (Lee et al., 2004).
Importantly, this phylogenetically conserved region also pos-
sesses the archetypal Nkx2.5 binding element in chicken, turkey,
zebra ﬁnch and frog (Fig. 3A, yellow boxed area). Interestingly,
while the equivalent region of the opossum genome lacks this
Nkx2.5 binding site, a sequence highly similar to a weaker-afﬁnity
Nkx2.5 binding site (C(A/T)TTAATTN) (Chen and Schwartz, 1995)
is present in a relative position 25 bp 50 to the expected position
of the archetypal site.
By contrast, an enhancer directly homologous to the CNkx2.5-
SHF enhancer was not apparent in Nkx2.5 genomic ﬂanking
regions of mice or other placental mammals. Several enhancer
elements of the mouse Nkx2.5 (mNkx2.5) gene are known to
regulate transgene expression in the E8.5–10.5 mouse heart,
some of which are responsive to BMP or the BMP pathway-
speciﬁc Smad proteins (Brown et al., 2003; Liberatore et al., 2002;
Lien et al., 1999; Reecy et al., 1999; Searcy et al., 1998). One of
these mNkx2.5 enhancers is well-conserved speciﬁcally in placen-
tal mammals and opossum (Fig. 3B) but strikingly absent in the
non-mammalian species analyzed above. This approximately
500 bp enhancer is located 9 kb 50 to the two major coding exons
of mNkx2.5. This distal 50 enhancer of mNkx2.5 regulates OFT and
RV expression in transgenic mouse reporter constructs utilizing
the heterologous hsp68lacZ promoter, requires interaction with
cardiogenic GATA transcription factors via consensus binding
elements for expression, and responds to Smad-mediated BMP
signaling in cell culture assays (Lien et al., 1999; Takeuchi et al.,
2005). Multispecies alignment of this enhancer in mammals
revealed conserved TF binding consensus sites for GATA, YY1
and Smad4 transcription factors also found in the conserved
central region of the CNkx2.5-SHF enhancer (Fig. 3B). This pattern
of conserved TF binding sites raised the possibility that this
mammalian enhancer, while divergent in sequence from the chick
enhancer, might regulate expression of Nkx2.5 in an analogous
manner. As shown in Fig. 4A–D, a chimeric reporter gene (here-
after referred to as mNkx2.5-SHF-lacZ) consisting of this distal 50
500 bp enhancer of mNkx2.5 and the chicken Nkx2.5 basaltic pole myocytes but not SHF progenitors. A–F: shown are representative lacZ
nstruct (nm lacZ). A–C: LacZ expression at E8.5 in PA mesoderm, ectoderm and
ee et al., 2004) with staining observed in pharyngeal arch regions containing SHF
Nkx2.5-SHFnm reporter fails to maintain lacZ expression in differentiating OFT and
G–I: Whole mount and sectioned whole mount in situ hybridization for cre mRNA
ed in pharyngeal arch endoderm, mesoderm and ectoderm overlapping with SHF
yngeal populations at E10.5 (H). J–L: Lineage tracing using R26R ROSA lacZ reporter
CNkx2.5-SHFnm-cre transgene marks pharyngeal arch ectoderm, endoderm, SHF
ilar to wild-type CNkx2.5-SHF-cre (SHF-Cre) (M–O). Abbreviations: PA: pharyngeal
rta; PuA: pulmonary artery; SV: sinus venosus; SHF: second heart ﬁeld mesoderm;
outline developing OFT/RV (A, I) and RV and LV (B) at E8.5.
Fig. 3. Divergent conserved enhancers mediate SHF expression of Nkx2.5 in mammalian and non-mammalian vertebrates. Shown in (A) is the central BMP response
element contained with the chicken Gallus gallus (Gg) Nkx2.5 SHF enhancer (CAR3) aligned with homologous 30 ﬂanking regions in the Nkx2.5 genes from the turkey
Meleagris gallopavo (Mg), Budgarigar or parakeet Melopsittacus undalatus (Mu), medium ground ﬁnch Geospiza fortis (Gf), zebraﬁnch Taenopygia guttata (Tg), frog Xenopus
tropicalis (Xt) and opossum Monodelphis domestica (Md). Homologous ﬂanking regions are at varying distances 30 from the transcriptional start site in these species, as
shown in the schematic at top. Conserved residues are shown in gray and divergent residues are highlighted in red. Consensus binding motifs are shown as colored boxes
for cardiac GATA (red), Smad4 (green), YY1 (blue) and Nkx2.5 (yellow). Underlined region highlights the previously characterized chicken Nkx2.5 BMPRE. (B) SHF enhancer
conserved in mammalian species. Shown are aligned Nkx2.5-50 enhancer sequences from mouse Mus musculus (Mm), rat Rattus norvegicus (Rn), human Homo sapiens (Hs),
chimp Pan troglodytes (Pt), orangutan Pongo pygmaetus abelii (Pa), dog Canis familiaris (Cf), horse Equus caballus (Ec), and opossum Monodelphis domestica (Md).TF site
highlighting is as in (A), except that a conserved Mef2 CArG binding consensus rather than an NKE is in yellow. Note that both enhancer motifs are conserved in opossum,
but lack either a strong Nkx2.5 binding motif (30 enhancer) or Mef2 binding CArG consensus (50 enhancer).
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Fig. 4. Mef2c interaction is required for SHF-speciﬁc expression of mNkx2.5-SHF enhancer in OFT and RV. Shown in A–D are representative transient whole mount and
section expression data for mNkx2.5-SHF-lacZ reporter transgenes combining the conserved 50 enhancer from mouse Nkx2.5 and the chicken Nkx2.5 proximal promoter.
Expression at E11.0 is observed in branchial arch ectoderm and mesoderm, and in the SHF derivatives of OFT and RV in the wild-type transgene mNkx2.5-SHF-lacZ (mSHF
WT). Planes of section in (C) and (D) are shown in (A) by white dashed lines c and d. (E) EMSA demonstrates preferential binding of Mef2c to the CArG consensus in the
conserved 50 enhancer of mouse Nkx2.5 over SRF (compare lane 3 to lane 4 and to binding of Mef2c to control Mef2c site in control lanes 8 and 9). Binding is lost upon
mutation of the central AT residues in the 50 mouse enhancer site (lane 4–6; 10–11). F. ChIP experiments show that Mef2c is associated with the 50 mNkx2.5 SHF enhancer
region and mNkx2.5 promoter proximal region in E10.5 heart tissue (Hrt) vs. pharyngeal arch tissue. (G) While overexpression of Mef2c alone has a modest impact on
mNkx2.5-SHF lux activity, much greater enhancement of basal and BMP-activated expression is observed with combined expression of Mef2c with SRF, Myocardin, p300
and cardiogenic GATAs. Increased activation is lost with Mef2c CArG box mutation (right-most columns). (H) Mutation of Mef2c binding CArG box consensus results in loss
of mNkx2.5-SHF enhancer activity. Representative Xgal staining pattern of E10.5 mouse embryo transgenic for mNkx2.5-SHFm2c-lacZ transgenic reporter bearing a point
mutation of the consensus Mef2c binding site (mSHF m2c). LacZ expression is lost in OFT and RV while expression in PA SHF mesoderm is relatively maintained (arrow).
Embryonic stages are shown in lower left. Abbreviations are as in previous ﬁgures.
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pattern highly similar to that seen with CNkx2.5-SHF-lacZ
(Lee et al., 2004). This mNkx2.5-SHF enhancer mediates this
function in its native 50 position relative to the basal promoter
(10/10 transient transgenic embryos), or when placed 30 to
promoter and coding sequences (5/5 transient transgenic
embryos) (Fig. 4A–D and data not shown).
Mef2c mediates sustained expression in SHF-derived conotruncal and
right ventricular myocytes of the mouse Nkx2.5 SHF enhancer
While the mNkx2.5-SHF enhancer shares several consensus ele-
ments in common with the CNkx2.5-SHF enhancer, it lacks an
apparent consensus-binding element for Nkx2.5. We noted that the
mNkx2.5-SHFenhancer instead contains a conserved CArG box binding
consensus potentially binding theMADS domain cardiac transcription
factor Mef2c (Martin et al., 1993) and that this site is correspondingly
absent in the chicken and non-mammalian SHF enhancers (Fig. 3B,compared to A). Gel shift or EMSA analysis shows that this site binds
to Mef2c but not to SRF, another MADS domain TF that recognizes
distinct A/T rich CArG sites Fig. 4E). Moreover, as shown in Fig. 4F
ChIP assay of chromatin derived from E10.5 mouse hearts using anti-
Mef2c antibody demonstrates enrichment for amplicons within the
mNkx2.5-SHF enhancer surrounding the mNkx2.5-SHF Mef2c binding
site, consistent with direct enhancer binding in vivo. With respect to
the mouse mNkx2.5-SHF enhancer, Mef2c expression appears to play
a role similar or parallel to that of Nkx2.5 expression for the chicken
CNkx2.5-SHF enhancer in that overexpression of Mef2c alone resulted
in minimal activation of the reporter whereas it greatly enhanced
reporter activation in response to the GATA4/6, Smad, SRF, Myocardin
and p300 transcription factor cocktail (Fig. 4G). The requirement for
Mef2c binding for enhancer activation was demonstrated by greatly
diminished activation of a construct (mNkx2.5-SHFm2c-lux) bearing a
mutation of the CArG consensus though BMP response is not affected
by this mutation (Fig. 4G, right hand columns). Similarly, in vivo
expression of a mNkx2.5-SHFm2c-lacZ transgenic reporter was greatly
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transgenic embryos) (Fig. 4H).Mef2c mediation of Nkx2.5 autoregulation
As the activation of the mNkx2.5-SHF reporter in cell assays by
Mef2c and combinatorial cardiac TFs was weaker than that observed
with the chick enhancer, we speculated that other factors were yet
required for more robust activation. Since Nkx2.5 and Mef2c are
capable of protein–protein interaction (Vincentz et al., 2008), we
considered the possibility that Mef2c binding actually mediates
Nkx2.5 recruitment and indirect autoregulation. Despite the lack of
an apparent NKE in its sequence, ChIP assay of chromatin derived
from E10.5 mouse hearts conﬁrms that Nkx2.5 binds in vivo to the
mNkx2.5-SHF enhancer region in E9.5 heart tissue (Fig. 5A). Cell assay
reveals that while Nkx2.5 by itself has no effect on mNkx2.5-SHF
activation, addition of Nkx2.5 with Mef2c, GATA4/6, SRF, Myocardin,
and p300 in cell-based assays results in an additional 2x activation of
the mNkx2.5-SHF-lux reporter (po0.02) (Fig. 5B). In order to test the
hypothesis that Nkx2.5 recruitment is the major function of Mef2c
binding to themNkx2.5-SHF enhancer, we replaced the Mef2c binding
CArG consensus site in this enhancer with the Nkx2.5 binding
consensus from the CNkx2.5-SHF chick enhancer and tested the
corresponding lacZ reporter construct in transient transgenic mouse
assays. As shown in Fig. 5(C–F), the resulting lacZ reporter (mNkx2.5-
SHFm2-NK-lacZ), like the wild-type reporter, is expressed in SHF-
derived PA and RV at E10.5 (4/6 transgenic embryos; 2 with no
expression), though PA mesodermal SHF-expression is not as appar-
ent in these transient embryos. By demonstrating that direct recruit-
ment of Nkx2.5 to this enhancer can in effect bypass the requirement
for Mef2c binding, this experiment both supports the hypothesis that
the principle role of Mef2c binding to the mNkx2.5 SHF enhancer is
Nkx2.5 recruitment, and conﬁrms that Nkx2.5 autoregulation of SHF
expression is conserved among vertebrates Fig. 6.Fig. 5. Mef2c CArG and NKE consensus sites are functionally interchangeable on
the mNkx2.5 SHF enhancer. (A) ChIP results demonstrating Nkx2.5 binding to the
native 50 mNkx2.5-SHF enhancer region in vivo in E10.5 heart vs. PA tissue. (B)
mNkx2.5-lux reporter gene is not signiﬁcantly activated by Nkx2.5 co-expression
alone, but addition of Nkx2.5 along with Mef2c and other cardiac TFs (multi-TF:
SRF, Myocardin. Gata4 and 6, p300) results in signiﬁcantly increased activation.
(C–F): Whole mount (C, D) and section (E, F) analysis of E10.5 embryo transgenic
for the mNkx2.5-SHF (m2-NKE) lacZ reporter where the CArG consensus binding
site has been altered to the Nkx2.5 binding NKE site from the cNkx2.5-SHF
enhancer. LacZ expression is highly similar to both CNkx2.5-SHF and mNkx2.5-
SHF lacZ reporters with expression largely in pharyngeal arch, OFT and RV
myocardium. Planes of section in (E) and (F) are shown in (C) by dashed white
lines e and f, respectively. Abbreviations are as in previous ﬁgures.Discussion
Conservation of Nkx2.5 autoregulation and its relationship to Mef2c
Here we identify autoregulation as an important aspect of
Nkx2.5 maintenance in the SHF. In addition we found that this
regulation is conserved in vertebrate species and is operative at a
critical juncture in OFT development. Interestingly, such a role for
Nkx2.5 in its own regulation may be evolutionarily conserved
since enhancer analysis of the archetypal tinman gene in Droso-
phila revealed that maintenance of Tinman in cardiogenic meso-
derm requires binding of Tinman itself (Xu et al., 1998). Similarly
cross-regulation of Nkx2.5 and Mef2 may represent a deeply
conserved module for early heart development. For example, in
Drosophila, sustained expression of tinman in cardiac mesoderm
requires binding of Tinman itself along with the Smad homolog
Mad to the 30 tin-D enhancer element that is conserved in multiple
Drosophila strains (Xu et al., 1998). The tin-D region also contains
several well-conserved but as yet uncharacterized CArG-like con-
sensus sites that might serve as binding sites for DMef2. DMef2
homozygous mutants initiate visceral and cardiac mesoderm
formation normally but later show abnormal cardiac and somatic
myocyte development indicating that DMef2 is dispensable for
early cardiac speciﬁcation but plays a more important role in
differentiation of myocytes from cardiac progenitors (Bour et al.,
1995). In addition, web-published databasesn report direct asso-
ciation of DMef2 to the 30 ﬂanking regions of tinman as detected by
ChIP assay of wild-type embryos at embryonic stages 10–13, and
altered TinmanmRNA expression is detected in Dmef2 null mutantembryos at these same stages. However, the issue of direct
regulation of tinman by Drosophila DMef2 remains to be deﬁned.
Further evidence supporting parallel roles of Mef2c and
Nkx2.5 in regulating SHF expression of Nkx2.5 in the mouse
comes from the intriguing observation that homozygous muta-
tions in both genes lead to similar looping defects (Lin et al., 1997;
Fig. 6. Summary model of direct and indirect autoregulation of Nkx2.5 SHF enhancers. Annotated model shows models of early activation of both mouse/mammalian 50
Nkx2.5 and Chick/non-mammalian 30 SHF enhancers by BMP via Gata, Smad and YY1 mediated mechanisms during early cardiac induction in SHF progenitors and later
maintenance of expression in cardiac myocytes of the aortic pole. Mouse/mammalian enhancer expression is maintained during cardiac differentiation in part through
recruitment of Nkx2.5 by protein–protein interaction with Mef2c in emerging heart cells (left). In chick and other avian or non-mammalian species SHF expression is
maintained by direct recruitment of Nkx2.5 to consensus enhancer binding sites. Model incorporates both ﬁndings in this work and referenced ﬁndings from previous
studies.
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target of Nkx2.5, (Tanaka et al., 1999) and we have preliminary
evidence of a quantitative loss of Nkx2.5 transcripts in Mef2c /
null hearts (Clark and Lee, unpublished). These results potentially
add another dimension to the cooperative nature of Nkx2.5 and
Mef2c transcriptional regulation in the SHF in addition to their
ability to co-regulate target genes through protein–protein inter-
action (Vincentz et al., 2008). While past work has found evidence
for SHF-speciﬁc regulation of Mef2c (Dodou et al., 2004), a direct
role for Mef2c function in SHF formation parallel to that of Nkx2.5
has yet to be determined either through examination of the
behavior of SHF lineages in Mef2c/ constituitive knockouts,
or through analysis of embryonic cardiac phenotypes resulting
from SHF-speciﬁc deletion of Mef2c.
Multifactor complex recruitment underlies SHF enhancer function
Our ﬁndings and those of other researchers present a model of
Nkx2.5 autoregulation in the SHF in which Nkx2.5 recruits similar
multi-TF complexes to enhancers that are functionally conserved
but divergent in sequence. This is consistent with an existing
paradigm for cardiac ﬁeld speciﬁcation suggesting that phenoty-
pic differentiation requires spatiotemporally overlapping expres-
sion of multiple TFs of the homeobox, zinc ﬁnger and helix-loop
helix domain familes. This paradigm of TF cooperativity has been
reinforced by the ﬁnding of reciprocal regulation between early
cardiac TFs during development (Davis et al., 2000; Lien et al.,
1999; Molkentin et al., 2000; Searcy et al., 1998; Ueyama et al.,
2003). Given the ability of many cardiac TFs to interact with and
recruit one another through protein–protein interactions, regula-
tory regions like the mouse and chicken SHF enhancers could
attract functionally similar or identical TF complexes specifying
similar cardiac ﬁelds while evincing limited sequence homology.
These ﬁndings also resonate with high-throughput analyses of
cardiac enhancers. A recent survey of cardiac-speciﬁc enhancers
associated with p300 recruitment in E11.5 day hearts of mice
found relatively poor sequence conservation of functionally con-
ﬁrmed heart enhancers as compared to forebrain-specifying
enhancers (Blow et al., 2010). Interestingly, this study also found
that the majority of predicted mouse heart enhancers were
conserved at the level of sequence only among other placentalmammals, indicating signiﬁcant divergence of such enhancers in
avians and amphibians much as we found with the Nkx2.5 SHF
enhancers. In this respect it is interesting to note that the
opossum Nkx2.5 gene possesses both the mammailan 50 and
non-mammalian 30 Nkx2.5 SHF enhancers (Fig. 3A and B) but that
the 50 enhancer lacks a strong binding consensus for Mef2c, and
the 30 enhancer contains a low-afﬁnity Nkx2.5 binding consensus
(Chen and Schwartz, 1995). This may suggest that SHF regulation
of the opossum gene depends upon the collaboration of two weak
enhancers rather than one strong one. As a marsupial, opossum
(Monodelphia domestica) is evolutionarily more distant from the
other mammals identiﬁed in our analysis and, along with mono-
tremes, may represent an independent evolutionary lineage from
those of avians and placental mammals.Nkx2.5 regulation and OFT malformation: integration of signals
controlling progenitor proliferation and differentiation
Nkx2.5 null mutant embryos have severe OFT and right heart
hypoplasia and previous studies have shown that this is caused in
part by disrupting the normal balance between proliferation and
differentiation of SHF cells. (Prall et al., 2007). Indeed, Nkx2.5
regulation is known to be intimately tied to several important
signaling pathways including BMP, the ﬁbroblast growth factors,
especially FGF8 and 4 (Alsan and Schultheiss, 2002; Barron et al.,
2000; Ilagan et al., 2006; Schultheiss et al., 1997; Tirosh-Finkel
et al., 2010; Waldo et al., 2001) and sonic hedgehog (Shh) (Dyer
et al., 2010; Zhang et al., 2001). Each of these signaling pathways
has been shown to regulate Nkx2.5 in either the ﬁrst or second
heart ﬁeld or in the context of OFT morphogenesis. In our current
study we demonstrate that Nkx2.5 SHF regulatory regions contain
consensus binding sites for Smad4, GATA and YY1, all of which
have been implicated in the direct activation of Nkx2.5 by BMP
(Fig. 3) (Lee et al., 2004). While it is possible that FGF and Shh act
at some level through secondary regulation of BMP signaling, our
ongoing work on species-comparative enhancer analysis will
explore the possibility that these and other morphogenic signals
directly regulate Nkx2.5 SHF expression through transcriptional
pathways collaborating with or competing against YY1/Smad-
mediated BMP activation.
C.D. Clark et al. / Developmental Biology 374 (2013) 198–209208Downstream of Nkx2.5 in the SHF, we have recently found that
Nkx2.5 directly regulates the early cardiac transcriptional reg-
ulator Jarid2 in SHF cells (Barth et al., 2010). As Jarid2 is a known
repressor of both cyclin D1 and cardiomyocyte proliferation in
embryonic hearts (Lee et al., 2000; Toyoda et al., 2003) and is a
key component of the PRC2 repressive complex that regulates the
activation of embryonic gene programs during the differentiation
of embryonic stem cells (Landeira et al., 2010; Li et al., 2010;
Pasini et al., 2010; Peng et al., 2009; Shen et al., 2009). Jarid2’s
dependence on normal Nkx2.5 expression for proper regulation is
yet another example of how the induction and maintenance of
normal Nkx2.5 expression controls OFT growth and morphogen-
esis. Through these coordinated studies we hope to obtain a more
global understanding of the Nkx2.5-centered regulatory tran-
scriptome controlling normal OFT development.Acknowledgments
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